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Abstract
Stomach/gastric ulcer is a debilitating disease affecting more than 10% of the global popula-
tion. Sufferers often have chronic pains with life-threatening gastrointestinal haemorrhage 
or perforation. Since the first diagnosis of stomach ulcer (SU) in the 19th century, excessive 
gastric juice that eroded the mucosa of the stomach was opined as its major cause. Efforts 
were channelled toward effective control of the resulting acid build-up through the use of 
antiulcer medications and reduction in stress-induced activities, which may aggravate gas-
tric hyperacidity. An intense treatment option involved vagotomy (surgically severing the 
nerves surrounding an ulcer) to prevent hyperacidity and further perforation of the stomach 
epithelium. Despite these interventions, SU disease remained an impediment to clinical prac-
tice. Literatures revealed that many botanicals have been used to treat SU and this is hinged 
on their being endowed with antiulcerogenic phytonutrients of therapeutic significance. In 
this review, attempts have been made to highlight the main mechanisms of action and limita-
tions of the conventional antiulcerogenic drugs, various antiulcerogenic experimental mod-
els, as well as compile selected medicinal plants and their implicated phytonutrients that will 
ultimately and eventually present effective and globally competitive exciting opportunities 
for the development of new lead therapeutics for the management of SU disorders.
Keywords: antiulcerogenic, gastric ulcer, gastropathy, hemorrhage, Helicobacter pylori, 
pepsin, perforation, phytonutrients, vagotomy
1. Introduction
Ulcer is an open sore of the biological membrane characterized by sloughing of inflamed 
dead tissue [1]. More specifically, it could either occur as a lesion on the surface of the skin 
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativeco mons.org/licenses/by/3.0), which permits unrestricted use,
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or a mucous membrane with significant superficial loss of tissue. Although, ulcers may be 
encountered at almost any part of the body, they are mostly found on the skin of the lower 
extremities and in the gastrointestinal tract [2]. There are many types of ulcer including 
mouth, esophageal, peptic and genital ulcer. Of these, peptic ulcer (PU) is the most prevalent 
[2]. The PUs are erosion of lining of either the stomach or duodenum [3] and this has availed 
the two most common types of PU as the gastric/stomach ulcer (SU) and duodenal ulcer. A 
person may have both gastric and duodenal ulcers at the same time. SUs are located in the 
stomach and mainly characterized by hemorrhage and pain. Other symptoms may include 
nausea, vomiting, and weight loss. Although patients with SU have normal or diminished 
acid production, yet ulcers may occur even in complete absence of acid [3]. Generally, pain 
occurs when the stomach is empty and relieves after eating. In some cases, SU can be life 
threatening with symptoms like bloody stool, severe abdominal pain, and cramps coupled 
with blood vomiting [4].
Under normal conditions, a physiologic balance exists between gastric acid secretion and 
mucosal defense. The epithelial cells of the stomach secrete mucus in response to irritation 
of the epithelial lining and as a result of cholinergic stimulation [5]. Ordinarily, the super-
ficial portion of the gastric mucosa is jelly-like and impermeable to acid and pepsin. Other 
gastric cells secrete bicarbonate, which buffers acid that lies penultimate to the mucosa. 
Also, the prostaglandins of the E (PGE) type of the epithelia offered significant protection 
by increasing the bicarbonate content and consequently strengthening the mucous layer. 
However, when the acid and pepsin enters the epithelial cells, further fortifying mecha-
nisms are triggered to ameliorate injury [5]. This may be best observed within the epithelial 
cells, where ion pumps in the basolateral cell membrane aids intracellular pH regulation 
through removal of excess H+ and subsequent migration of healthy cells to the site of injury. 
By so doing, the acid that diffused through the injured mucosa is effectively removed by 
the flow of blood in the mucosa. This also provides bicarbonate to the superficial epithe-
lial cells. However, when there is disequilibrium between offensive (acid, pepsin, and 
Helicobacter pylori) and defensive factors (mucin, prostaglandin, bicarbonate, nitric oxide, 
and growth factors), the pathophysiological features of SU become evident [6]. Although, 
SU was once believed to be caused by spicy food and stress, they have however been estab-
lished to be mere aggravating factors while the real causes include reaction to various 
medications, particularly nonsteroidal anti-inflammatory drugs (NSAIDS) and H. pylori 
infection [7]. H. pylori, NSAIDS, emotional stress, alcohol abuse, and smoking are the prin-
cipal etiological factors associated with SU [8]. Usually, SU occur as breaks across the entire 
length of the stomach epithelia and in some cases, the deeper layers of the muscle wall are 
considerably affected. This disruption of the mucosal integrity may potentiate perforation, 
bleeding, obstruction, pain and death, if proficient treatments are not timely administered. 
The exclusive production of urease by H. pylori renders its microenvironment alkaline and 
allows its long-lasting survival in the hostile acidic environment of the stomach, where it 
either worsens the severity of SU disease or merely causes mucosal inflammation. More 
often in SU cases, inflammation is secondary to the colonizing action of H. pylori on the 
gastric mucosa [5]. In patients infected with H. pylori, high levels of gastrin and pepsinogen 
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and reduced levels of somatostatin have been measured [5]. Most patients with SU have 
impaired gastric bicarbonate secretion, which has also proven to be caused by H. pylori 
because its eradication reverses the defect [9]. Similarly, pepsin (a proteolytic enzyme) and 
HCl are both essential for food digestion but at the same time have the tendency to erode 
the cell linings of the digestive system if secreted in excess. Although, the stomach defends 
itself from these aggravating factors by creating a mucus coating and producing bicarbon-
ates, H. pylori infection and NSAIDS can impair the protective functions and make the 
linings of the gastrointestinal tract susceptible to HCl and pepsin action and consequently 
results in the formation of ulceration [10].
Globally, SU is the most prevalent gastrointestinal disorder ever known, affecting more 
than 10% of people and accounting for an estimated 15,000 mortality yearly [11]. The annual 
incidence of SU perforation and hemorrhage were 3.8–14.0 and 19.4–57.0 per 100,000 per-
sons, respectively and this is anticipated to further worsen if no practical and viable alterna-
tives are sought [12]. Specifically in the United States, PU disease affects approximately 4.5 
million people annually and about 10% of the US population has evidence of a SU at some 
point in their life time [5]. Initially, PU diseases were more prevalent in the male popu-
lations but the current statistics suggest quite similar figures in both males and females 
with the overall lifetime prevalence tending toward 8–11% and 11–14% in women and men, 
respectively [5]. The age trends for the occurrence of PU show appreciably declining rates in 
younger males, while it is increasing steadily in older women. The statistics for SU disease 
in other countries is variable and is hinged primarily on the major causes of the disease: 
H. pylori and NSAIDs [13].
Although, orthodox medicine has provided succor in the management of SU disease over 
the years, a significant percentage of the global population still use traditional systems 
of medicine to manage and treat SU due to better cultural acceptability, improved com-
patibility, affordability, and lesser side effects [14]. The present study was conducted to 
review medicinal plants considered as gastroprotective and healing agents on SUs with 
particular focus on selected antiulcerogenic botanicals and their implicated phytonutri-
ents. To achieve this, information were retrieved from online databases (Google, Pubmed, 
MEDLINE, Science Direct, Scopus and SID) in form of published articles, books, confer-
ence proceedings and other high profile intellectual resources. The retrieved studies either 
showed effectiveness of these plants or indirectly their efficacy on the involved mechanisms 
in the treatment of SU.
2. The conventional therapy for stomach ulcer management
SU therapy has witnessed many strides over the last decades and a number of drugs are now 
available for its treatment. Since the occurrence of SU disease is attributable to either pepsin 
action and hyperacidity or inadequate mucosal resistance, hence, its effective management 
lies exclusively in stemming the aggressive factors or fortify the defensive mechanisms. A 
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corner stone in this approach was the advent of histamine H
2
-receptors and the respective 
antagonist [15], which signified a landmark achievement in the management of disorders 
characterized by gastric hypersecretion. The H
2
-antagonists were instantaneously identified 
as potent and safe agents which may replace the previously used drugs. For instance, the 
appearance of cimetidine (an H
2
-antagonist agent), led to the virtual disappearance of drugs 
of unknown mechanism like gefarnate, sulphoglycopeptide, amilopectine, zolimidine, xyl-
amide, etc. Despite the inherent improvement witnessed with the use of the H
2
-antagonist 
over the previously used drugs, their untoward reactions have undermined their appre-
ciable application. Generally, the antiulcer drugs may be classified according to the site and/
or mechanism of action as: (a) antacids; (b) gastric muscle stimulants; (c) agents which pro-
tect the mucosa, increase mucosal resistance or coat ulcer craters; (d) antisecretory drugs, 
which may be anticholinergic agents; (e) corticohypothalamic drugs; and (f) proton pump 
inhibitors.
2.1. Antacids
It is noteworthy that either antacid mixtures or combinations of antacids with other com-
pounds are more commonly used than single-entity antacids [15]. These kinds of formulation 
have been made to elicit a better neutralizing effect and to extenuate side effects associated 
with single constituent entities. The calcium and aluminium combinations reduce diarrhea 
while magnesium caters well for constipation. Similarly, a combination of slow- and fast-
acting agents could increase the total buffering time. More improved benefits are claimed 
for mixtures having alginic acid (a foam-forming agent), which floats above the gastric juice 
with eventual aiding of contact between the antacid and the mucosa. In the event of gas-
troesophageal reflux, the alginic acid appears to prevent reflux by being the first to come 
in contact with the esophagus. By so doing, further erosion by the gastric acid is effectively 
prevented. Also, when simethicone (dimethylpolysiloxanes with characteristics antifoaming 
and water-repellant properties) is used, defoaming the gastric juice to reduce flatulence and 
gastroesophageal reflux is achieved. However, the resulting contributory adverse effects of 
the respective constituent in the antacid especially gastric irritation are a major challenge 
consistent with the use of antacids.
2.2. Gastric muscle stimulants
In individuals with stomach atony where there is consequential prolonged contact time between 
acid and mucosa due to the delay in gastric emptying, stimulants of gastric motility produce 
satisfactory outcomes. Domperidone and metoclopramide are the two most widely used com-
pounds in this category. While both accelerates gastric emptying in experimental animals and 
humans, the metoclopramide still acts via other four important mechanisms that have made 
it more potent: (i) a cholinergic effect on muscarinic receptors; (ii) a direct effect on smooth 
muscle; (iii) an effect on specific centers regulating gastrointestinal motility; and (iv) a release of 
motilin which could be strongly responsible for the effects on the proximal bowel [15].
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2.3. Mucosa protecting agents
Compounds like sucralfate, carbenoxolone and chelated bismuthate belong to this class of 
drugs. The sucralfate (a complex of sucrose and aluminium hydroxide) potentiates its action by 
inhibiting gastric hydrolysis with significant affinity for ulcerated mucosa. It forms a complex 
with susceptible proteins (fibrinogen, albumin etc) that adhere to the ulcerated area, thereby 
shielding against acid, pepsin action and penetration of bile acid. The merits of sucralfate over 
other antiulcer drugs relate to a lack of systemic effect due to the poor absorption of the com-
pound [16]. The disadvantages include a certain delay in gastric emptying and constipation 
which affects almost 2% of the sufferers. Furthermore, compliance is another issue of con-
cern as sucralfate must be taken four times daily (q.i.d.) and at least one hour before meals to 
be optimally effective. While chelated bismuthate and carbenoxolone works quite similar to 
sucralfate, appreciable incidence of aldosterone-like adverse effects (sodium and fluid reten-
tion, hypertension etc) have hampered their use.
2.4. Drugs with antisecretory effect
2.4.1. Anticholinergics
Despite that the drugs in this class have been used for many years, information on their 
ulcer healing capacity is still elusive. This may be attributable to the radiological method 
that was initially used but later found not to be very effective in wound healing assessment. 
Hyoscyamine, atropine, phentonium, propantheline and methantheline with characteristic 
ganglion-blocking and antimuscarinic effects are the classical examples of anticholinergics. 
Subsequent to the discovery and acceptance of the H
2
-antagonists, the anticholinergics virtu-
ally disappeared due to inherent adverse effects of dry mouth, blurring of vision, delay in 
gastric emptying, tachycardia, possible constipation, and urinary retention.
2.4.2. H
2
-antagonists
Undoubtedly, the H
2
-antagonists are the most significant agents for the management and 
treatment of SU and for pathological conditions characterized by hyperacidity. Burimamide 
(the prototype of H
2
-antagonists) was faced-out because of low oral activity and toxicological 
concerns. Similarly, metiamide (the 2nd agent in the series), was orally active but potenti-
ated significant bone marrow toxicity in clinical trials. Cimetidine (still the most widely used 
antiulcer drug), is the 3rd drug in this class and well over 70 million sufferers have so far 
benefitted from its pharmacological efficacy till date. This was closely followed by ranitidine, 
which was the first agent with an alkyl furan ring, which substituted the imidazole ring 
of the preceding H
2
- antagonists. More recent reports however suggest that optimum H
2
-
antagonism may also be achieved also with other different agents. For this class of drugs, not 
only could potency and efficacy be optimized, the pharmacokinetics could also be modified 
with the known duration of action of 4–6 h, exclusive to the ‘short-acting’ H
2
-blockers [17], 
optimized to and beyond 24–48 h to have ‘long-acting’ H
2
-blockers. Generally, over the last 
The Purview of Phytotherapy in the Management of Gastric Ulcer
http://dx.doi.org/10.5772/intechopen.70007
27
three decades, the most frequently used H
2
-antagonists in clinical practice are cimetidine, 
ranitidine and famotidine [2]. However, many adverse reactions such as effects on the endo-
crine, cardiovascular and central nervous systems (CNS) have been associated with these 
drugs.
2.5. Corticohypothalamic drugs
A role has been established for the CNS in the regulation of gastric secretion and in the patho-
genesis of peptic ulcer, although clarification is required in many areas. It is not surpris-
ing that drugs which act specifically on the CNS may exert a beneficial effect on SU, which 
sometimes is significantly better than other drugs. Trimipramine is a tricyclic antidepressant 
which causes a slight decrease in gastric secretion that is apparently not connected with its 
anticholinergic action. Like other traditional tricyclic antidepressants, it may have some H
2
-
antagonistic effects and may also act on α-adrenoceptors enhancing catecholamine avail-
ability at central synapses [18], or may depress central vagal function. However the use of 
trimipramine in non-depressed ulcer patients is questionable.
2.6. Proton pump inhibitors (PPIs)
At present, PPIs are the most commonly prescribed class of antiulcer drugs. Their mode of 
action involves blockage of the site of gastric acid secretion in the parietal cell of the stomach 
[19]. However, because the parietal cells are constantly reproducing in millions, effective inhi-
bition of gastric acid secretion is almost unachievable and this partly explains their relative 
safety compared to other groups of antiulcer drugs. In general, the incidence of short-term 
adverse effects subsequent to PPI usage is relatively low and this may be the reason for their 
being well tolerated. Their long-term use has not been frequently studied and the dearth of 
information in this regards has made it difficult to make definitive statements [20]. For all 
the PPIs (omeprazole, lansoprazole, dexlanprazole, esomeprazole, pantoprazole, rabeprazole 
and ilaprazole), the occurrence of adverse effects are similar, though they have been reported 
more frequently with omeprazole. This may be due to its longer availability. The common 
adverse effects with PPIs include headache, nausea, diarrhea, abdominal pain, fatigue and 
dizziness. Infrequent adverse effects may also include rash, itch, flatulence, constipation, anx-
iety, depression, myopathies and rhabdomyolysis [21].
3. Ulcer inducing agents/models
The pathological mechanisms of SU disease that compromises its functional capability and 
the structural integrity has been established to arise mainly through either production of too 
much acid and pepsin, or weakening of the gastric epithelia that consequently results in too 
little mucosal resistance [2]. Table 1 shows some of the known ulcerogenic agents/models and 
the pathological mechanism involved in their ulcer pathogenesis. A good understanding of 
the pathogenic mechanism of action of these models is crucial to spotting and either manag-
ing or preventing ulceration and the associated disorders.
Stomach Disorders28
4. Some scientifically validated antiulcerogenic medicinal plants
Despite the rapidly changing concept of SU disease management from conventional vagot-
omy, H
2
-receptor antagonists and antacids to proton pump inhibitors, gastrointestinal toxic-
ity and other inherent adverse effects remain significant impediments to their application in 
clinical practice. Investigation on the phytotherapeutic applications of medicinal plants that 
are highly valued and widely used in the traditional systems of medicine have been and still 
providing efficient formulation for better management of SU [2, 22].
The under-listed medicinal plants have been pharmacological reported to possess antiulcer 
activity as previously compiled [34–39]. They are:
Acacia arabica (Family: Mimosaceae); Abutilon indicum L. (Family: Malvaceae); Adansonia 
digitate; Aegle marmelos (Family: Rutaceae); Allium sativum (Family: Liliaceae); Allophylus ser-
ratus Kurz (Family: Sapindaceae); Aloe vera (Family: Liliaceae); Alstonia scholaris; Annona 
squamosa (Family: Annonaceae); Asparagus racemosus; Azadirachta indica (Family: Meliaceae); 
Bacopa monnieri; Benincasa hispida; Bauhinia purpurea (Family: Leguminosae); Bauhinia variegate 
(Family: Caesalpiniaceae); Berberis aristata; Beta vulgaris; Buchanania lanzan Spreng. (Family: 
Agent/model Underlying mechanism Reference(s)
NSAIDs (aspirin, indomethacin and 
ibuprofen)
Gastric acid secretion and inhibition of prostaglandin 
synthetase activity
[22]
Water-immersion/cold-restraint stress Release of histamine resulting in increased acid secretion, 
decreased mucus production and poor flow of gastric blood
[23, 24]
Ethanol Solubilizes mucous membrane and renders it vulnerable to 
the proteolytic and hydrolytic actions of HCl and pepsin
[25]
Acetic acid Induces round, deep ulcers in the stomach through over 
production of acid secretion
[26]
Histamine Acid stimulating and vasodilating effect that results to 
increased vascular permeability of the gastric mucosa
[27]
Reserpine Degranulation of gastric mast cells consequent to histamine 
liberation that is facilitated by cholinergic system
[28]
Serotonin Causes vasoconstriction thereby reducing gastric mucosal 
blood flow resulting to acute mucosal injury
[29]
Pylorous-ligation Accumulation of gastric acid that consequently produces 
ulcer subsequent to the breakdown of gastric mucosal 
barriers
[30]
Ischemia-reperfusion Causes erosion of the gastric epithelia due to free radicals 
formation
[31]
Acetic acid-H. pylori Increased acid secretion and decreased mucus production [32]
Iron-ascorbic acid Linked with lipid peroxidation mediated by oxygen radicals [33]
Table 1. Commonly used experimental models for ulcer induction.
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Anacardiaceae); Butea frondosa Roxb. (Family: Fabaceae); Boswellia serrata (Family: Burseraceae); 
Careya arborea (Family: Myrtaceae); Carica papaya (Family: Caricaceae); Capsicum annuum L. 
(Family: Solanaceae); Centella asiatica; Cissus quadrangularis L. (Family: Vitaceae); Curcuma longa L. 
(Family: Zingiberaceae); Desmostachya bipinnata (L.) Stapf (Family: Gramineae); Desmodium gan-
geticum; Emblica officinalis (Family: Euphorbiaceae); Excoecaria agallocha (Family: Euphorbiaceae); 
Garcinia cambogia; Glycyrrhiza glabra (Family: Leguminosae); Ficus arnottiana; Ficus religiosa 
(Family: Urticaceae); Hemidesmus indicus; Hibiscus rosa sinensis (Family: Malvaceae); Ipomoea 
batatas L. (Family: Convolvulaceae); Ixora pavetta (Family: Rubiaceae); Kielmeyera coriacea Mart 
(Family: Guttiferae); Lagenaria siceraria (Family: Cucurbitaceae); Leucas lavandulifolia Sm. (Family: 
Labiatae); Mangifera indica (Family: Anacardiaceae); Mimosa pudica (Family: Fabaceae); Mentha 
arvensis L. (Family: Lamiaceaea); Momordica charantia (Family: Cucurbitaceae); Momordica cym-
balaria Hook. (Family: Cucurbitaceae); Morinda citrifolia; Moringa oleifera (Family: Moringaceae); 
Musa sapientum; Myrtus communis (Family: Myrtaceae); Ocimum sanctum (Family: Lamiaceae); 
Oryza sativa (Family: Gramineae); Phyllanthus niruri (Family: Euphorbiaceae); Plectranthus amboini-
cus; Polyalthia longifolia (Family: Annonaceae); Psidium guyava (Family: Myrtaceae); Rhus coriaria 
(Family: Anacardiaceae); Rhizophora mangle L. (Family: Rhizophoraceae); Sapindus trifoliatus L. 
(Family: Sapindaceae); Sesbania grandiflora (Fabaceae); Shorea robusta (Family: Dipterocarpaceae); 
Solanum nigrum (Family: Solanaceae); Tamarindus indica (Family: Caesalpiniaceae); Tamarindus 
indica (Family: Caesalpiniaceae); Tecomaria capensis (Family: Bignoniaceae); Terminalia che-
bula (Family: Combretaceae); Terminalia pallida; Utleria salicifolia Bedd. Ex.Hook. F. (Family: 
Periplocaceae); Vinca minor L. (Family: Apocynaceae). A comprehensive list of some selected 
plants being embraced as antiulcerogenic agents is presented in Table 2.
Plant Family Plant used Phytonutrients Reference(s)
Acacia arabica Mimosaceae Gum, leaves Arabic acid, malate, sugar, mineral 
elements, tannins
[40, 41]
Achyranthus aspera Amaranthaseae Root, seeds Saponin, glycosides [42]
Adansonia digitata Malvaceae Leaves Mucilage, glucose, albuminoids, 
adansonin, tannin
[43]
Aegle marmelos Rutaceae Leaves Flavonoid, tannins, saponin [44]
Aleo vera Liliaceae Whole plant Aloin, isobarbaloin, emodin, 
saponin
[45]
Alhagi maurorum Fabaceae Root Terpenes, saponin, tannins [46]
Allium sativum Liliaceae Bulb Mucilage, starch, albumen, 
vitamins, sugar, allicin, alliin
[47]
Annona squamosa Annonaceae Leaves Alkaloids, flavonoids, saponini, 
tannins
[48]
Azadirachta indica Meliaceae Leaves Saponin, flavonoids, phenolics, 
tannin
[49]
Bauhinia variegate Caesalpiniaceae Stem-bark, root Rutin, quercetin, apigenin, tannin [50]
Berberis aristata Berberidaceae Root Alkaloids [51]
Bata vulgaris Chenopodiaceae Root Betin [52]
Carica papaya Caricaceae Fruit, seeds Papain, pectin, carpaine, carposide [53]
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Plant Family Plant used Phytonutrients Reference(s)
Centella asiatica Apiaceae Whole plant Flavonoids, narigin, alkaloids, 
saponin, asiatic acid
[54]
Cordial myxa Fruit Tannins, carbohydrate, saponin [55]
Ficus exasperata Moraceae Leaves, stem-bark Flavonoids, saponin, alkaloids, 
glycosides, tannins
[2]
Ficus religiosa Urticaceae Stem-bark Tannins, wax, cochtone [56]
Gossypium barbadense Malvaceae Leaves Gossypol, saponin, steroids, 
cardiac glycosides
[22]
Gossypium herbaceous Malvaceae Flowers Flavonoids, phenolics, saponin [57]
Hibiscus rosa sinensis Malvaceae Root Phenolics, cyanidin, hydrocitrate [58]
Langeneria breviflora Cucurbitaceae Fruit, leaves Saponin, phenolics, cucurbitacin [59]
Langeneria siceraria Cucurbitaceae Fruit Flavonoids, steroids, phenols, 
saponin
[42]
Mangifera indica Anacardiaceae Leaves Alkaloids, sterols, saponin, tannins, 
flavonoids, mangiferin
[60]
Momordica tuberose Cucurbitaceae Tubers Alkaloids, tannins, saponin [61]
Moringa oleifera Moringaceae Leaves Quercetin, β-sitoterol, β-carotene, 
alkaloids, tannins, saponin
[62]
Musa paradisiacal Musaceae Root, leaves, 
trunk
Tannins, starch, vitamin C, 
albuminoids
[42]
Myrtus communis Myrtaceae Leaves Resin, tannins, citrate, malate, 
sugar
[63]
Nerium indicum Apocynaceae Flowers Alkaloids, glycosides, flavonoids, 
phenolics, tannins
[64]
Ocimum sanctum Lamiaceae Leaves Alkaloids, tannins, saponin, 
flavonoids, sterols
[65]
Oryza sativa Gramineae Grain, bran Starch, mineral matter, protein [66]
Phyllanthus niruri Euphorbiaceae Whole plant Alkaloids, tannins, flavonoids, 
carbohydrate, glycosides
[67]
Prunus amygdalus Rosaceae Seeds, fruit Ursolic acid, quercetin, flavonoids [42]
Psidium guyava Myrtaceae Leaves, stem-bark Resin, tannins, cellulose, 
flavonoids, quercetin, quajaverin
[68]
Rhus coriaria Anacardiaceae Whole plant Tannins, flavonoids [69]
Sesbania grandiflora Fabaceae Leaves Saponin, tannins, triterpenes [70]
Smilax china Smilacaceae Root Tannins, resin, saponin, flavonoids [71]
Solanum nigrum Solanaceae Leaves Flavonoids, saponin, alkaloids, 
phytosterols
[72]
Spondias mombin Anacardiaceae Leaves Tannins, saponin, flavonoids, 
phenolics, glycosides
[73]
Tamarindus indica Caesalpiniaceae Leaves, seeds Albuminoids, fiber, pectin, tannins [74]
Terminalia chebula Combretaceae Leaves Gallic acid, sorbitol, tannins, 
mucilage
[75]
Table 2. Some selected medicinal plants with antiulcerogenic properties.
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Following the experimental demonstration that many medicinal plants are endowed with 
good antiulcerogenic activity with relatively lesser adverse effect compared with the conven-
tional drugs, further steps have been taken in presenting a good number of them for clinical 
trials. Despite this giant stride, not many of the medicinal plants have passed market entry 
stage. To the best of our knowledge, of the many presented for developmental evaluations in 
2004, only Azadirachta indica (Family: Meliaceae) received remarkable attention at its advance 
stage of clinical trial. It exhibited significant therapeutic potency by reducing gastric hyperse-
cretion, gastroesophageal and gastroduodenal ulcers [76].
5. Phytonutrients associated with antiulcerogenic activity
Several phytonutrients have proven health benefits and have been reported to elicit sig-
nificant antiulcerogenic potential in both humans and experimental animal models [73]. 
While steroid glycosides, tannins, terpenoids and flavonoids have been shown to preserve 
gastric mucosal against oxidative insults of reactive metabolites and oxidative stress [22, 
59], the tendency of phenolic compounds and alkaloids to regulate gastric acid secretion 
and protect the gastric mucosal epithelia against erosion and other aggressive factors in dif-
ferent ulcer models have been demonstrated [77]. While Table 1 also presents some of these 
phytonutrients as being responsible for the elicited antiulcerogenic properties of the plants, 
several others have also been identified and isolated from diverse plants. Some of these 
include; saponins, phobaphenes, glucose, luvangetin, tartarate, potash, nimbidin, quercetin, 
apigenin, papain, chymopapain, pectin, carposide, carotenoids, antheraxanthin, carpaine, 
resin, euphorbon, caoutchouc, rutin, anthocyanins, cyanindin, kaempferol, sterols, muci-
lage, terpenoids, kaepferom, ash, starch, fats, proteins, glycosides, ellagic acid, beta sitos-
terol, gallic acid, limonene, pinene, albuminous matter, cellulose, chlorophyll, mineral salts, 
myricitin, triterpenes, and sorbitol [37]. These compounds have either been elucidated to 
decrease acid/pepsin secretion or confer cytoprotection via effective modulation on mucosal 
defensive factors.
6. Some selected medicinal plants with antiulcerogenic properties in 
Nigeria
In Nigeria, SU remains a significant public health challenge affecting people of all ages. While 
its management through orthodox medicine has recorded substantial successes over the 
years, a considerable proportion of the populace still rely exclusively on complementary and 
alternative medicine (CAM) in seeking aid to treat and manage SU. This may be due to the 
ease of accessibility, affordability and minimal side effect associated with the use of medicinal 
plants [22]. A compilation of selected antiulcerogenic medicinal plants in Nigeria revealed 
that the most widely used plants in the management of SU are Occimum basillicum, M. para-
disiaca, Aloe vera, Azadiracter indica, Brassica oleracae and Carica papaya [78]. Others include 
but not limited to the following: Diodia sarmentosa, Cassia nigricans, Ficus exasperate, Synclisia 
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scabrida, Artocarpus heterophyllus Lam., Blighia sapida Konig., Dialium guineense Willd., Emblica 
officinalis Gaertn., Gongronema latifolium, Ageratum conyzoides, Aloe vera, Artocarpusaltilis, Aspilia 
africana, Bryophyllum pinnatum, Fluerya aestuans, Musa paradiasiaca, Musa sapientum, Persea 
Americana, Talinum triangulare, Fluerya aetuans, Brassica oleracae, Acacia nilotica L., Alchornea 
cordifolia Schum & thonn, Anacardium occidentale L., Balanites aegyptiaca L., Bridelia ferruginea 
Benth, Carica papaya Linn, Ficus thonningii Blume, Guiera senegalensis J. F. Gmel, Hibiscus sab-
dariffa L., Mangifera indica L., Momordica charantia L., Ocimum gratissium L., Piliostigma reticu-
latum (DC) Hochst, Pisidium guajava L., Scoparia dulcis, Vernonia kotschyana Sch. Bip., Zingiber 
officinale Rosc [79].
7. The role of medicinal plants in oxidative gastropathy
Reactive oxygen species (ROS) are a by-product of normal metabolism and have roles in cell 
signaling and homeostasis [80]. Mechanisms exist that regulate cellular levels of ROS, as their 
reactive nature may otherwise cause damage to key cellular components including DNA, 
protein, and lipids [81]. A good number of NSAIDS have been implicated in cellular toxicity 
leading to oxidative gastropathy [82]. Despite the use of NSAIDS as antipyretic and anti-
inflammation agents, and in the treatment of rheumatic, musculoskeletal, and cardiovascular 
diseases [83], gastrointestinal toxicity through ROS formation has limited their application [84, 
85]. It has been proposed that NSAID-mediated gastrointestinal lesions involve the uncou-
pling of oxidative phosphorylation and inhibition of electron transport chain causing incom-
plete reduction of oxygen [82]. This they do by tenaciously binding to a site near complex I 
and ubiquinone, thus facilitating events leading to ROS generation [86, 87]. Subsequently, 
when the gastric antioxidant capacity is overwhelmed, the epithelia mitochondrial aconitase 
is inhibited, resulting in the release of iron that reacts with H
2
O
2
, producing hydroxyl radical. 
These cascades of event amplify gastric oxidative stress whose consequential effect is mani-
fested as gastropathy [88]. Oxidative stress-induced functional loss is well correlated with 
numerous disease states including cardiovascular, neurological, cancer, aging processes and 
gastropathy [83] and is also implicated in a variety of drug-induced toxicities such as SU [2]. 
Antioxidative and free radical scavenging mechanisms play an important role in the protec-
tion against ROS mediated toxicities [89]. Over the past decades, interests in medicinal plants, 
especially the antioxidative ones, have increased appreciably and they have been elucidated 
to significantly either protect against or ameliorate ROS-mediated oxidative gastropathy [22, 
90]. Such annihilation of ROS in SU diseases have been achieved through induction of enzy-
mic antioxidants (superoxide dismutase, catalase, glutathione reductase and peroxidase) and 
optimization of reduced glutathione (GSH) contents [2, 22, 59]. Harmonizing the foregoing, a 
probable mechanism of antioxidative and gastroprotective activities of medicinal plants may 
be idealized as illustrated in Figure 1. This ultimately involves induction and optimization 
of preventive (catalase, glutathione peroxidase) and chain-breaking (superoxide dismutase, 
glutathione reductase) antioxidants that subsequently improve gastric GSH level, annihilate 
liberated reactive metabolite and effectively scavenge ROS (O
2
−, OH−) (Figure 1). This may 
also be opined to regulate mucosal fluidity and strengthens defensive mechanisms against 
oxidative gastric damage.
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8. Conclusion
Globally, SU is a devastating disease posing serious threat to the quality of life of humans. 
It affects significant proportion of the populace in both developed and developing countries. 
Although, conventional drugs have been used to manage and treat SU sufferers, affordability 
and inherent side effects have limited their application. Consequently, alternatives are being 
sought in medicinal plants, which provide a potential source of antiulcerogenic drugs and are 
widely used in traditional systems of medicine. Several medicinal plants have been investi-
gated for their proven health benefits in SU management with their phytonutrients playing 
significant roles. Of the phytonutrients, tannins seem to top the list and has suggested prob-
able focus on their characterization for antiulcer therapy. In spite of the impressive experi-
mental evaluation of medicinal plants for the treatment of SU, very few have reached clinical 
trials and not very many have been marketed. This indicates that the intended benefits of 
CAM research are not yet having far-reaching effect. Nevertheless, the continuous search for 
Figure 1. Probable mechanism of antioxidative and gastroprotective capabilities of medicinal plants. The dotted  arrows 
represent sites of induction and optimization by the plants that consequently promote scavenging of O
2
− and OH−. 
This will normalize and increase gastric reduced glutathione (GSH) content and promotes its mobilization toward 
detoxification of the liberated reactive metabolites. NSAIDS, nonsteroidal anti-inflammatory drugs; MP, medicinal 
plants; GPx, glutathione peroxidase; GRx, glutathione reductase; GSSG, oxidized glutathione.
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antiulcerogenic agents of plant origin (available as gifts of nature) is imperative. This will 
ultimately and eventually present effective and globally competitive exciting opportunities 
for the development of new lead therapeutics for SU and other related disorders.
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